Zuletzt aktualisiert: 25. August 2026
Prostate cancer depends on testosterone to grow. Take the testosterone away and the cancer shrinks, often dramatically and often for years. That is androgen deprivation therapy, and it is one of the most effective treatments in urology.
It also asks a great deal of the man taking it. An earlier version of this article described how ADT works and how it is monitored without mentioning a single side effect. That was a serious omission on a page men read before starting treatment, and most of what follows is the correction.
- Urologisches Zentrum, Bangkok Hospital, Thailand Online-Terminbuchung 02-310-3009 bhquro@bdms.co.th
- Samitivej Sriracha Hospital Chonburi 088-022-1445
What it does, precisely
Prostate cancer cells are dependent on androgens to grow. Reducing testosterone to very low levels removes the fuel, and the cancer regresses.
It is worth being precise here, because the earlier wording — that testosterone drives prostate cancer aggressiveness — is easily misread. A man with a higher natural testosterone level is not thereby at greater risk of prostate cancer, and prostate tissue is already saturated at ordinary levels. What is true is the reverse direction: once a cancer exists, removing androgen starves it. That distinction matters to anyone reading this site’s pages on testosterone therapy as well.

When it is used
The earlier version said ADT is reserved for advanced disease. That is where it is most familiar, but it is not the whole picture, and the narrower statement has been corrected.
- Metastatic disease — the mainstay, usually now combined with additional agents rather than given alone.
- Alongside radiotherapy in intermediate- and high-risk disease that is still confined to the prostate, where adding ADT for a defined period improves the outcome of the radiotherapy.
- When the PSA rises after surgery or radiotherapy, depending on how fast it is rising.
- Where the cancer is localised and curable, ADT is not the treatment — surgery or radiotherapy is. See radical prostatectomy and how staging decides the route.
How testosterone is lowered
- Surgical removal of both testes — immediate, permanent, requires nothing further and costs nothing ongoing. It remains a perfectly reasonable option, chosen less often because it is irreversible and because many men find the idea difficult.
- LHRH agonists such as leuprolide or goserelin, given as injections at intervals from monthly to yearly. These work by overstimulating the pituitary until it shuts down — which produces an important quirk, described below.
- GnRH antagonists, given by injection or, in one case, by mouth. These block the signal directly instead of overstimulating it. They lower testosterone faster, cause no initial surge, and are worth discussing where cardiovascular disease is a concern. The earlier version of this article did not mention this class at all.

The first two weeks on an agonist: tumour flare
This was absent from the earlier version and is the one acute hazard of starting treatment.
Because LHRH agonists work by overstimulating the pituitary before exhausting it, testosterone rises sharply for the first week or two before it falls. In a man with extensive disease that brief surge can make the cancer temporarily more active — causing worsening bone pain, difficulty passing urine, or, most seriously, pressure on the spinal cord.
This is why an anti-androgen tablet is usually started shortly before the first injection and continued for a few weeks to cover the surge, and why an antagonist may be chosen instead in men most at risk. If you were not offered cover, ask why — and see the emergency symptoms below.
What ADT costs you — the section that was missing
These are common, not rare. Knowing about them beforehand makes them considerably easier to live with, and several can be actively managed rather than simply endured.
- Hot flushes — the commonest complaint, and treatable.
- Loss of sexual desire and erectile dysfunction, in most men. This is not a side note; it is often the hardest part, and it is worth discussing openly before starting rather than discovering afterwards.
- Fatigue, loss of muscle and strength, and weight gain, particularly around the abdomen. Resistance exercise genuinely counteracts this and is among the few things with good evidence behind it.
- Bone thinning, and fractures. Bone loss on ADT is rapid, and a fracture in this setting is a serious event. Bone density is assessed, and calcium, vitamin D, weight-bearing exercise and — for some men — bone-protecting medication are part of proper care rather than optional extras.
- Metabolic and cardiovascular effects — rising cholesterol, insulin resistance and new or worsening diabetes. Blood pressure, glucose and lipids belong in the monitoring, and a man with existing heart disease should have that weighed when the type of ADT is chosen.
- Mood change, low mood, and difficulty with memory and concentration. Men frequently do not connect these to the treatment and so never mention them.
- Breast tenderness or enlargement, and loss of body hair.
None of this is an argument against ADT where it is indicated. It is an argument for going into it with your eyes open, and for the follow-up to look at more than the PSA.
Monitoring
- PSA, at intervals, watching the trend rather than any single value.
- Testosterone, to confirm suppression has actually been achieved — a step that is skipped more often than it should be. The conventional target is below 50 ng/dL, with some evidence favouring a lower threshold still.
- Bone density, plus calcium and vitamin D.
- Blood pressure, glucose and lipids.
If the PSA rises while testosterone is confirmed to be at castrate level, the disease has become castration-resistant — which is not the end of treatment but the point at which further agents are added. There are considerably more of those available now than there were a few years ago.

Symptoms that are an emergency
Im Notfall in Thailand rufen Sie an: 1669.
- New weakness or numbness in the legs, difficulty walking, or loss of control of the bladder or bowel. This may be pressure on the spinal cord and is the most time-critical emergency in prostate cancer — treatment within hours preserves function that is otherwise lost permanently. Do not wait until morning.
- Severe or rapidly worsening bone pain, especially in the first weeks of an agonist.
- Unfähigkeit, Wasser zu lassen mit einer schmerzhaften Füllung der Blase.
- Chest pain, sudden breathlessness, or pain and swelling in one calf.
- A fall with pain afterwards, in a man who has been on ADT for some time — bone thinning makes fractures easier.
Frequently Asked Questions About ADT
What are the side effects of androgen deprivation therapy?
Common and expected rather than rare: hot flushes, loss of desire and erectile dysfunction, fatigue, muscle loss and weight gain, bone thinning with fracture risk, rising cholesterol and blood sugar, low mood, difficulty concentrating, and breast tenderness. An earlier version of this article listed none of them. Several can be actively managed, which is why they are worth raising rather than tolerating.
What is tumour flare, and does it affect me?
LHRH agonists cause testosterone to rise for the first week or two before it falls, which can briefly worsen the cancer’s activity — bone pain, urinary obstruction, or pressure on the spinal cord in men with extensive disease. An anti-androgen tablet is usually given around the first injection to cover it, or a GnRH antagonist chosen instead, since antagonists cause no surge.
Is surgical removal of the testes still an option?
Yes, and it remains reasonable. It is immediate and permanent, needs no further injections and no ongoing cost, and its side effects are those of low testosterone rather than of the operation. It is chosen less often because it cannot be undone and because many men find the idea difficult, which is a legitimate reason.
Does high testosterone cause prostate cancer?
No. Existing prostate cancer depends on androgen to grow, which is what makes ADT work, but a higher natural testosterone level does not put a man at greater risk of developing the disease. These are different questions and are often confused.
Will I be on ADT for life?
It depends on why it was started. Given alongside radiotherapy for localised disease it usually runs for a defined period and then stops, and testosterone recovers over months, sometimes incompletely. In metastatic disease it generally continues. In some situations it is given intermittently, with breaks, to reduce the burden of side effects.
My PSA is rising while I am on ADT. What does that mean?
First, testosterone is checked to confirm suppression is genuinely being achieved. If it is, the disease has become castration-resistant — which is a point at which further treatments are added rather than the end of treatment.
Terminvereinbarung
Dr. Soarawee Weerasopone behandelt Patienten am Bangkok Hospital Headquarters (BHQ) und am Samitivej Sriracha Hospital in Chonburi am 088-022-1445. Bring every previous PSA result with its date, the biopsy and staging reports, and a list of your other medicines and conditions — heart disease, diabetes and bone problems all bear on which form of ADT suits you.
Die Telemedizin des Bangkok Hospital steht Patienten zur Verfügung, die nicht persönlich erscheinen können, auch internationalen Patienten — vereinbaren Sie sie vorab per E-Mail mit der Abteilung für Urologie unter bhquro@bdms.co.th. Samitivej Sriracha bietet ausschließlich Vor-Ort-Termine an. Anfragen zu den Kosten werden vom Krankenhaus beantwortet, nicht von dieser Website.
Haftungsausschluss: Dieser Inhalt wurde von Dr. Soarawee Weerasopone, einem Facharzt für Urologie am Bangkok Hospital Headquarters, verfasst und geprüft und dient ausschließlich der Information. Er stellt keine medizinische Beratung, Diagnose oder Verschreibung für einzelne Personen dar; über private Nachrichtenkanäle oder soziale Medien werden keine Beratung, Diagnose oder Verschreibung erteilt. Dr. Soarawee betreibt kein öffentliches Social-Media-Konto; jedes Konto, das in seinem Namen eine private Beratung anbietet, ist betrügerisch. Im Notfall in Thailand rufen Sie an: 1669.
Medizinisch verfasst und geprüft von: Dr. Soarawee Weerasopone (Dr. Pom) — Facharzt für Urologie, Bangkok Hospital Headquarters, in urologischer Praxis seit 2016. Fellowship: Roboterchirurgie, Chang Gung Memorial Hospital, Taiwan (2019) · Hospitanz: Endourologie, Juntendo University Hospital, Tokio (2022) · Forschungsstipendiat und klinischer Beobachter, Scott Department of Urology, Baylor College of Medicine, USA (2025–2026).

Dr. Soarawee Weerasopone (Dr. Pom) ist Board-zertifizierter Urologe am Bangkok Hospital Headquarters mit den Schwerpunkten Männergesundheit, robotische Chirurgie (da Vinci Xi) und Behandlung von Nierensteinen. Er absolvierte zwei klinische Fellowships am Chang Gung Memorial Hospital, Taiwan (2019), in Andrologie sowie in Robotischer Chirurgie & Minimalinvasiver Urologie, eine endourologische Observership am Juntendo University Hospital, Tokio (2022), und eine Position als Research Scholar and Clinical Observer am Scott Department of Urology des Baylor College of Medicine unter Prof. Mohit Khera (2025–2026).

